Systemic treatment
Clinically relevant biological response
Our products and research services help generate exacting and clinically relevant data to more accurately predict product performance in vivo. TenSkinTM treated with RTA-408 (an NRF2 activator) exhibited a biological response (i.e., upregulation of NQOl mRNA) similar to in vivo data, while traditional ex vivo models (cultured without tension) showed little response.
